Authors


Alison Sexton Ward, PhD

Latest:

The Long-term Social Value of Granulocyte Colony-Stimulating Factors

Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.


Bruce W. Sherman, MD

Latest:

Trust Between Patients and Clinicians: An Overlooked and Affordable Approach to Improving US Health Care

Raising the visibility of the importance of trust in patient-clinician relationships can help ensure it is acknowledged and incorporated into policy and tactical considerations.



Nancy A. Perrin, PhD

Latest:

More Comprehensive Discussion of CRC Screening Associated With Higher Screening

More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.


Judy L. Benkeser, BSN, RN

Latest:

Excess Hospitalization Days in an Academic Medical Center: Perceptions of Hospitalists and Discharge Planners

We assessed the frequency of and reasons for medically unnecessary hospital days, which affect patients, payers, hospitals, and healthcare providers.






Sarah Sullivan, BS

Latest:

Benchmarking Health-Related Quality-of-Life Data From a Clinical Setting

Health-related quality-of-life data are often collected during routine clinical care. We present a method to create nationally representative benchmarks for clinical subspecialties.


Natalie Oake, MSc

Latest:

Interactive Voice Response Systems for Improving Delivery of Ambulatory Care

A systematic review of interactive voice response system studies showed that these interventions significantly benefit adherence to various processes of care.







Rebecca Piegari, MS

Latest:

Which Patients Are Persistently High-Risk for Hospitalization?

Most patients in a large integrated healthcare system who were high-risk for hospitalization were at substantially lower risk within 2 years.




Jason M. Broderick

Latest:

FDA Approves Perioperative Pembrolizumab in Resectable HNSCC

The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC whose tumors express PD-L1 with a CPS of ≥1.






Mazi Rasulnia, PhD, MBA, MPH

Latest:

Evaluating the Efficacy of a Bundled Chronic Condition Management Program

A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.


Adam Sharp, MD, MSc

Latest:

Delivery of Acute Unscheduled Healthcare: Who Should Judge Whether a Visit Is Appropriate (or Not)?

More consideration should be focused on consumer decision making and the quality and costs of acute care, and less attention should be paid to where care is delivered.


Institute for Healthcare Improvement

Latest:

The Blueprint for Complex Care: Laying the Groundwork to Build a Field Across Sectors

Complex care is cross-sector and person-centered, and it could bend America’s healthcare cost curve. The Blueprint for Complex Care gives this new field a national framework.


Elexis McBee, DO

Latest:

There's More Than One Way to Build a Medical Home

Even among practices reaching the highest level of PCMH achievement, there are variations in the implementation of key medical home capabilities.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo